Home › FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL
 

Keywords :   


FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

2014-08-29 14:50:24| Biotech - Topix.net

Mylan Inc. today announced that its abbreviated new drug application for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration .

Tags: filing generic accepts anda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.05Meat prices expected to increase slightly this summer
13.05Innovia launches hot melt barrier film for fridge and freezer labels
13.05Pennsylvania law aims to protect domestic animals, food supply against disease
13.05Ongoing influenza A surveillance critical for U.S. swine herd health
13.05Warning over 'disastrous' BBC podcast advert plan
13.05Axalta to Acquire The CoverFlexx Group
13.05Manufacturer in Australia Achieves Zero-Waste Milestone Through Sustainable Initiatives
13.05SONGWON Signs The Antwerp Declaration for a European Industrial Deal
More »